Craft

ARTIVION

Stock Price

$26.7

2024-10-29

Market Capitalization

$1.1 B

2024-10-29

Revenue

$441.3 M

FY, 2025

ARTIVION Summary

Company Summary

Overview
CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. Its medical devices and processed tissues primarily include four product families: BioGlue Surgical Adhesive, JOTEC endovascular and surgical products, On-X mechanical heart valves and surgical products, and cardiac and vascular human tissues including the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch. The company also provides surgical cardiac lasers for treatment of refractory angina, and technology and surgical training in adult and pediatric cardiovascular surgery.
Type
Public
Status
Active
Founded
1984
HQ
Kennesaw, GA, US | view all locations
Website
http://www.cryolife.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • J. Patrick MacKin

    J. Patrick MacKin, Chairman, President, and Chief Executive Officer

  • Thomas F. Ackerman
  • Jean F. Holloway

    Jean F. Holloway, Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary

  • Daniel J. Bevevino

    Daniel J. Bevevino, Director

    Operating MetricsView all

    Warehouse Space, sq. ft.

    14.4K

    FY, 2018

    Patents (US)

    39
    4.9%

    FY, 2018

    Patents (Foreign)

    135
    18.4%

    FY, 2018

    LocationsView all

    5 locations detected

    • Kennesaw, GA HQ

      United States

      1655 Roberts Blvd

    • Austin, TX

      United States

      1300 E Anderson Ln Bldg. B

    • Paris, Île-de-France

      France

      52 Rue de la Victoire

    • Singapore

      Singapore

      1 Marina Blvd, 28

    • Guildford, England

      United Kingdom

      The Guildway, Old Portsmouth Rd

    ARTIVION Financials

    Summary Financials

    Revenue (Q1, 2026)
    $116.3M
    Gross profit (Q1, 2026)
    $75.4M
    Net income (Q1, 2026)
    $1.4M
    Cash (Q1, 2026)
    $55.8M
    EBIT (Q1, 2026)
    $5.8M
    Enterprise value
    $1.3B

    Footer menu